1.0The Medical Xchangehttps://themedicalxchange.com/en/Chapter 3: Treatments – Pharmacology - The Medical Xchangerich600338<blockquote class="wp-embedded-content" data-secret="ly1LXFTAvr"><a href="https://themedicalxchange.com/en/review/chapter-3-treatments-pharmacology/">Chapter 3: Treatments – Pharmacology</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://themedicalxchange.com/en/review/chapter-3-treatments-pharmacology/embed/#?secret=ly1LXFTAvr" width="600" height="338" title="“Chapter 3: Treatments – Pharmacology” — The Medical Xchange" data-secret="ly1LXFTAvr" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script type="text/javascript">
/* <![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://themedicalxchange.com/wp-includes/js/wp-embed.min.js
/* ]]> */
</script>
https://themedicalxchange.com/wp-content/uploads/2017/06/2510_HSDD_sexual_health_EN_Chap3_Fig2.png960720Atlanta – Hypoactive sexual desire disorder (HSDD) is estimated to affect about one in every 10 adult women1 . Several promising pharmacotherapies for HSDD are currently in clinical trials as adjuncts to traditional sex therapy. These include hormonal treatments and agents that target the central nervous system (CNS) to increase sexual excitation or decrease sexual inhibition in specific centers of the brain that are crucial for sexual desire. These novel pharmacological agents are new tools in a more comprehensive and patient-oriented approach to the treatment of HSDD.